New research covers treating MS early, identifying those at risk for AED-induced psychosis, & selecting a drug for epilepsy patients with migraines.
Early treatment of new onset multiple sclerosis (MS) with interferon Î²-1b therapy leads to clinical benefits. Several risk factors may help identify epilepsy patients who may be at higher risk for psychosis due to their antiepileptic drug treatment. Topiramate is an appropriate treatment for epilepsy patients with comorbid migraine.
Value of early MS treatment. Abstract link.
Early treatment of MS with interferon Î²-1b therapy can reduce the risk for conversion to clinically definite MS and decrease relapse rates.
Identifying anti-epilepsy drug-induced psychosis. Abstract link.
Topiramate for Epilepsy Patients with Migraine. Abstract link.
Topiramate is a reasonable first line option in newly diagnosed epilepsy patients who also have migraine headaches.